PhilipsCA, KedarisettyCK. Palliative care for patients with end-stage liver disease. J Clin Exp Hepatol, 2023; 13(2):319–328.
2.
WallingAM, AhluwaliaSC, WengerNS, et al.Palliative care quality indicators for patients with end-stage liver disease due to cirrhosis. Dig Dis Sci, 2017; 62(1):84–92.
3.
HaepN, FlorentinoRM, SquiresJE, et al.The inside-out of end-stage liver disease: Hepatocytes are the keystone. Semin Liver Dis, 2021; 41(2):213–224.
4.
GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol, 2020; 5(3):245–266.
5.
TerraultN, FrancozC, BerenguerM, et al.Liver transplantation 2023: Status report, current and future challenges. Clin Gastroenterol Hepatol, 2023; 21(8):2150–2166.
6.
KwongAJ, EbelNH, KimWR, et al.OPTN/SRTR 2021 annual data report: Liver. Am J Transplant, 2023; 23(2 Suppl 1):S178–S263.
7.
JadlowiecCC, TanerT. Liver transplantation: Current status and challenges. World J Gastroenterol, 2016; 22(18):4438–4445.
8.
PengJK, HepgulN, HigginsonIJ, et al.Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med, 2019; 33(1):24–36.
9.
BaumannAJ, WheelerDS, JamesM, et al.Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage, 2015; 50(6):882–886.e2.
10.
LambaS, MurphyP, McVickerS, et al.Changing end-of-life care practice for liver transplant service patients: Structured palliative care intervention in the surgical intensive care unit. J Pain Symptom Manage, 2012; 44(4):508–519.
11.
ShinallMC, KarlekarM, MartinS, et al.COMPASS: A pilot trial of an early palliative care intervention for patients with end-stage liver disease. J Pain Symptom Manage, 2019; 58(4):614–622.e3.
12.
KimbellB, MurraySA, ByrneH, et al.Palliative care for people with advanced liver disease: A feasibility trial of a supportive care liver nurse specialist. Palliat Med, 2018; 32(5):919–929.
13.
WoodlandH, HudsonB, ForbesK, et al.Palliative care in liver disease: What does good look like? Frontline Gastroenterol, 2020; 11(3):218–227.
14.
DunnSH, RogalSS, MaierMM, et al.Access to comprehensive services for advanced liver disease in the veterans health administration. Dig Dis Sci, 2019; 64(12):3471–3479.
15.
ShehadahA, Yu NaingL, BapayeJ, et al.Early palliative care referral may improve end-of-life care in end-stage liver disease patients: A retrospective analysis from a non-transplant center. Am J Med Sci, 2024; 367(1):35–40.
16.
GuptaK, HansB, KhanA, et al.A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol, 2022; 14(9):1817–1829; doi: 10.4254/wjh.v14.i9.1817
17.
PatelAA, WallingAM, Ricks-OddieJ, et al.Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol, 2017; 15(10):1612–1619.e4.
18.
UfereNN, DonlanJ, WaldmanL, et al.Barriers to use of palliative care and advance care planning discussions for patients with end-stage liver disease. Clin Gastroenterol Hepatol, 2019; 17(12):2592–2599.
19.
DonlanJ, UfereNN, IndrioloT, et al.Patient and caregiver perspectives on palliative care in end-stage liver disease. J Palliat Med, 2021; 24(5):719–724.
20.
EstebanJPG, ReinL, SzaboA, et al.Attitudes of liver and palliative care clinicians toward specialist palliative care consultation for patients with end-stage liver disease. J Palliat Med, 2019; 22(7):804–813.
21.
FerrareseA, BucciM, ZanettoA, et al.Prognostic models in end stage liver disease. Best Pract Res Clin Gastroenterol, 2023; 67:101866.
22.
WeissmanDE, MeierDE. Identifying patients in need of a palliative care assessment in the hospital setting: A consensus report from the Center to Advance Palliative Care. J Palliat Med, 2011; 14(1):17–23.
